• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过活细胞成像评估介孔硅球中二硫键药物载体的内涵体逃逸作用。

Role of endosomal escape for disulfide-based drug delivery from colloidal mesoporous silica evaluated by live-cell imaging.

机构信息

Department of Chemistry and Center for Nanoscience, University of Munich LMU, Butenandtstrasse 11, Gerhardt-Ertl-Building, 81377 Munich, Germany.

出版信息

Nano Lett. 2010 Sep 8;10(9):3684-91. doi: 10.1021/nl102180s.

DOI:10.1021/nl102180s
PMID:20677799
Abstract

Redox-driven intracellular disulfide-cleavage is a promising strategy to achieve stimuli-responsive and controlled drug release. We synthesized colloidal mesoporous silica (CMS) nanoparticles with ATTO633-labeled cysteine linked to the inner particle core via disulfide-bridges and characterized their cysteine release behavior after internalization into HuH7 cells by high-resolution fluorescence microscopy. Our study revealed that endosomal escape is a bottleneck for disulfide-linkage based drug release. Photochemical opening of the endosome leads to successful delivery of fluorescently labeled cysteine to the cytosol.

摘要

氧化还原驱动的细胞内二硫键断裂是一种很有前途的策略,可以实现刺激响应和控制药物释放。我们合成了胶体介孔硅(CMS)纳米粒子,其内部颗粒核心通过二硫键连接有 ATTO633 标记的半胱氨酸,并通过高分辨率荧光显微镜研究了它们内化进入 HuH7 细胞后的半胱氨酸释放行为。我们的研究表明,内涵体逃逸是基于二硫键的药物释放的一个瓶颈。内涵体的光化学打开导致荧光标记的半胱氨酸成功递送到细胞质中。

相似文献

1
Role of endosomal escape for disulfide-based drug delivery from colloidal mesoporous silica evaluated by live-cell imaging.通过活细胞成像评估介孔硅球中二硫键药物载体的内涵体逃逸作用。
Nano Lett. 2010 Sep 8;10(9):3684-91. doi: 10.1021/nl102180s.
2
PEGylated mesoporous silica as a redox-responsive drug delivery system for loading thiol-containing drugs.聚乙二醇化介孔二氧化硅作为一种用于负载含硫醇药物的氧化还原响应型药物递送系统。
Int J Pharm. 2014 Dec 30;477(1-2):613-22. doi: 10.1016/j.ijpharm.2014.10.056. Epub 2014 Oct 31.
3
Mesoporous silica nanoparticles capped with disulfide-linked PEG gatekeepers for glutathione-mediated controlled release.用二硫键连接的聚乙二醇作为介孔二氧化硅纳米粒子的盖帽,用于谷胱甘肽介导的控制释放。
ACS Appl Mater Interfaces. 2012 Jun 27;4(6):3177-83. doi: 10.1021/am3005225. Epub 2012 Jun 7.
4
Designing Mesoporous Silica Nanoparticles to Overcome Biological Barriers by Incorporating Targeting and Endosomal Escape.设计介孔硅纳米粒子,通过整合靶向和内涵体逃逸来克服生物屏障。
ACS Appl Mater Interfaces. 2021 Mar 3;13(8):9656-9666. doi: 10.1021/acsami.0c21507. Epub 2021 Feb 17.
5
Hyaluronic acid oligosaccharide modified redox-responsive mesoporous silica nanoparticles for targeted drug delivery.用于靶向给药的透明质酸寡糖修饰的氧化还原响应性介孔二氧化硅纳米粒子
ACS Appl Mater Interfaces. 2014 Nov 26;6(22):20290-9. doi: 10.1021/am505824d. Epub 2014 Oct 24.
6
Breakable mesoporous silica nanoparticles for targeted drug delivery.用于靶向给药的可断裂介孔二氧化硅纳米颗粒。
Nanoscale. 2016 Apr 7;8(13):7240-7. doi: 10.1039/c5nr09112h.
7
Fluorescent carbon dot modified mesoporous silica nanocarriers for redox-responsive controlled drug delivery and bioimaging.用于氧化还原响应性控释药物递送和生物成像的荧光碳点修饰介孔二氧化硅纳米载体
J Colloid Interface Sci. 2016 Dec 1;483:343-352. doi: 10.1016/j.jcis.2016.08.033. Epub 2016 Aug 13.
8
γ-PGA-coated mesoporous silica nanoparticles with covalently attached prodrugs for enhanced cellular uptake and intracellular GSH-responsive release.γ-PGA 修饰的介孔硅纳米粒子,通过共价键连接前药,提高细胞摄取效率和细胞内 GSH 响应释放。
Adv Healthc Mater. 2015 Apr 2;4(5):771-81. doi: 10.1002/adhm.201400726. Epub 2015 Jan 12.
9
Hindered disulfide bonds to regulate release rate of model drug from mesoporous silica.阻碍二硫键调节模型药物从介孔硅中的释放速率。
ACS Appl Mater Interfaces. 2013 May;5(9):3908-15. doi: 10.1021/am400604d. Epub 2013 Apr 25.
10
Introduction of disulfide bridges within silica nanoparticles to control their intra-cellular degradation.在二氧化硅纳米粒子中引入二硫键以控制其细胞内降解。
Chem Commun (Camb). 2013 Apr 28;49(33):3410-2. doi: 10.1039/c3cc41062e.

引用本文的文献

1
Effect of physicochemical properties on fate of nanoparticle-based cancer immunotherapies.物理化学性质对基于纳米颗粒的癌症免疫疗法命运的影响。
Acta Pharm Sin B. 2021 Apr;11(4):886-902. doi: 10.1016/j.apsb.2021.03.007. Epub 2021 Mar 9.
2
Multifunctional Delivery Systems for Peptide Nucleic Acids.用于肽核酸的多功能递送系统。
Pharmaceuticals (Basel). 2020 Dec 25;14(1):14. doi: 10.3390/ph14010014.
3
Controlled Nutrient Delivery to Pancreatic Islets Using Polydopamine-Coated Mesoporous Silica Nanoparticles.使用聚多巴胺包覆的介孔硅纳米粒子实现对胰岛的受控营养物质输送。
Nano Lett. 2020 Oct 14;20(10):7220-7229. doi: 10.1021/acs.nanolett.0c02576. Epub 2020 Sep 21.
4
Multimodal Decorations of Mesoporous Silica Nanoparticles for Improved Cancer Therapy.用于改善癌症治疗的介孔二氧化硅纳米颗粒的多模态修饰
Pharmaceutics. 2020 Jun 8;12(6):527. doi: 10.3390/pharmaceutics12060527.
5
Recent Advances in Porphyrin-Based Inorganic Nanoparticles for Cancer Treatment.基于卟啉的无机纳米粒子在癌症治疗中的最新进展。
Int J Mol Sci. 2020 May 9;21(9):3358. doi: 10.3390/ijms21093358.
6
Photochemical Internalization for Intracellular Drug Delivery. From Basic Mechanisms to Clinical Research.用于细胞内药物递送的光化学内化:从基本机制到临床研究
J Clin Med. 2020 Feb 14;9(2):528. doi: 10.3390/jcm9020528.
7
Biodegradable Periodic Mesoporous Organosilica (BPMO) Loaded with Daunorubicin: A Promising Nanoparticle-Based Anticancer Drug.载有柔红霉素的可生物降解的周期性介孔有机硅(BPMO):一种有前途的基于纳米粒子的抗癌药物。
ChemMedChem. 2020 Apr 3;15(7):593-599. doi: 10.1002/cmdc.201900595. Epub 2020 Feb 11.
8
Ultrasound Reversible Response Nanocarrier Based on Sodium Alginate Modified Mesoporous Silica Nanoparticles.基于海藻酸钠修饰介孔二氧化硅纳米粒子的超声可逆响应纳米载体
Front Chem. 2019 Feb 11;7:59. doi: 10.3389/fchem.2019.00059. eCollection 2019.
9
Monitoring the Stimulated Uncapping Process of Gold-Capped Mesoporous Silica Nanoparticles.监测金封端介孔硅纳米粒子的去帽刺激过程。
Anal Chem. 2018 Mar 6;90(5):3183-3188. doi: 10.1021/acs.analchem.7b04532. Epub 2018 Feb 15.
10
Nanoparticles: augmenting tumor antigen presentation for vaccine and immunotherapy treatments of cancer.纳米颗粒:增强肿瘤抗原呈递,用于癌症的疫苗和免疫治疗。
Nanomedicine (Lond). 2017 Dec;12(23):2693-2706. doi: 10.2217/nnm-2017-0254. Epub 2017 Nov 3.